We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,586.00
Bid: 1,584.00
Ask: 1,586.00
Change: -4.00 (-0.25%)
Spread: 2.00 (0.126%)
Open: 1,572.00
High: 1,591.00
Low: 1,569.00
Prev. Close: 1,590.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths establishes Euro Medium Term Note Programme

18 Oct 2016 07:00

RNS Number : 7487M
Smiths Group PLC
18 October 2016
 

 

News Release

London, 18 October 2016

For immediate release

 

 

Smiths Group establishes a Euro Medium Term Note Programme

Smiths Group plc ("the Company") announces today that it has established a €2.5 billion Euro Medium Term Note Programme ("the EMTN programme") with its ten relationship banks as dealers.

The EMTN programme will facilitate the issuance by the Company of senior notes over time in various currencies and maturities as a continuing element of its financing strategy. Notes issued under the EMTN programme will be guaranteed by Smiths Group International Holdings Limited and will rank pari passu with all of the Company's outstanding senior notes and other debt obligations.

Chris O'Shea, Chief Financial Officer, said:

"This programme underpins Smiths Group's existing strategy to finance our balance sheet from the rated public debt markets. It provides us with increased flexibility in refinancing our debt maturities over the next two years, and in financing portfolio management activities, such as the agreement we announced in April to acquire Morpho Detection."

A base prospectus dated 17 October 2016 relating to the establishment of the EMTN programme ("the Prospectus") has been approved by the UK Listing Authority and is available for viewing.

To view the Prospectus, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/7487M_-2016-10-17.pdf

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do. 

ENDS

 

 

Contact details

 

Investor enquiries

Andrew Lappin, Smiths Group

+44 (0)20 7004 1657

+44 (0)78 5461 1966

andrew.lappin@smiths.com

 

Kirsty Law, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

kirsty.law@smiths.com

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

 

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs 22,000 people in over 50 countries. For more information visit www.smiths.com

 

 

Disclaimer - intended addressees

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. Neither the Prospectus nor this announcement is intended for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUBDGRXBBGLR
Date   Source Headline
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities
1st Feb 202410:15 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirectors' Change in Responsibilities
30th Nov 20237:00 amRNSSmiths Group plc - John Crane deep dive
16th Nov 20231:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSSmiths Group plc - Q1 Trading Update
2nd Nov 20232:45 pmRNSDirector/PDMR Shareholding
1st Nov 202310:00 amRNSBlock listing Interim Review
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:25 pmRNSDirector/PDMR Shareholding
12th Oct 202312:35 pmRNSAnnual Financial Report and AGM 2023
4th Oct 202310:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:10 pmRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSSmiths Group FY23 Full Year Results
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.